Clinical Trials Logo

Clinical Trial Summary

Clopidogrel is a medication that is used to decrease the ability of platelets to form blood clots.

The theory has been proposed that, in patients with coronary artery disease or stroke, increased platelet function after discontinuation of clopidogrel therapy is associated with an increased clotting risk. However, this theory has never been rigorously tested.

The goal of this research is to determine whether discontinuation of clopidogrel results in increased platelet function.


Clinical Trial Description

In this study, we will address the question: does discontinuation of clopidogrel result in platelet hyperreactivity? We will perform a double-blind, placebo-controlled, crossover study in normal subjects, in whom platelet reactivity will be measured before clopidogrel or placebo, during clopidogrel or placebo, and at various time points after discontinuation of clopidogrel or placebo. The dose of clopidogrel will be the standard, FDA-approved dose: 75 mg daily. All subjects will be treated with aspirin 81 mg daily throughout the 57 days of study assessment in both the clopidogrel arm and the placebo arm, because the clinically relevant question is: in patients who remain on aspirin, does discontinuation of clopidogrel result in platelet hyperreactivity? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00619073
Study type Interventional
Source University of Massachusetts, Worcester
Contact
Status Completed
Phase N/A
Start date April 2008
Completion date May 2009

See also
  Status Clinical Trial Phase
Recruiting NCT03613337 - Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention
Completed NCT01582217 - Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition N/A
Completed NCT02484924 - The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
Completed NCT01960296 - Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding? Phase 2
Completed NCT04431349 - Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel
Completed NCT00753753 - VerifyNow French Registry N/A
Completed NCT05512546 - The Prevention of Thromboembolic Complications Associated With Coil Embolization
Completed NCT01231867 - Cohort Study of Clopidogrel and Proton Pump Inhibitors N/A
Withdrawn NCT00363753 - Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack Phase 1